A new use for a common device called the Vagus Nerve Stimulator could help CFS and FM patients handle the depression that often accompanies their disease.
The pacemaker-like device currently used to treat epilepsy is being evaluated as a possible new treatment for depression by healthcare psychiatrists at the University of California at San Diego (UCSD). Known as the Vagus Nerve Stimulator, the device will be implanted in 10 to 15 severely depressed San Diegans who have not responded to medication or psychotherapy. This development could help CFS and FM patients, who often experience depression with their conditions.
The Vagus Nerve Stimulator seems to help about 40% of the patients who participated in the University of Texas open-treatment pilot study, according to Mark Rapaport, M.D., UCSD associate professor of psychiatry. “Those severely depressed patients who did have a positive response had a remarkable change in their lives,” he said. The findings are published in the journal Biological Psychiatry.
Since the nerve stimulator was approved by the Food and Drug Administration in 1997 for the treatment of epilepsy, more than 7,000 patients have used the device. About the size of a stopwatch, the Vagus Nerve Stimulator is implanted in the upper chest during outpatient surgery. Guide wires are tunneled up the neck and wrapped around the left vagus nerve, which connects to several parts of the brain that are involved in mood and emotion.
The current study is a double-blind trial where all patients will have the stimulator off for a certain period of time followed by nine months of follow-up monitoring with the stimulator active. This study will occur in 20 sites in the US and the patients must meet rigorous entry criteria. The current study is funded by Cyberonics, a Houston, Texas company that manufactures the Vagus Nerve Stimulator.
Chronic diseases, by their very nature can often lead to depression. Symptoms of depression vary from individual to individual but often include lack of appetite, lack of enthusiasm for daily activities and insomnia. However, researchers have recently begun to recognize the importance of helping patients handle depression. When people feel mentally better able to manage their condition symptoms may improve and recovery can be speeded up.
According to national mental health organizations, 17-19 million Americans suffer from depression and an estimated one to three million are deemed treatment-resistant. These individuals get little or no help from medications, visits to the doctor, and shock treatments.
For more information, call UCSD Psychopharmacology Research Program at (858) 622-6105.